Tumor-associated fibrosis plays a role in cellular immunity across human diseases.
This review summarizes current understanding of the cellular and molecular drivers of fibrotic tumor stroma, highlighting heterogeneous cancer-associated fibroblast (CAF) types, and provides a comprehensive framework for understanding how tumor-associated fibrosis regulates cellular immunity across cancers.